Wells' Criteria for DVT
Calculates risk of DVT based on clinical criteria.
There are several versions of these criteria with minor variations across studies; this version, based on Wells 2003, is among the most widely validated.
- As with all clinical decision aids, this tool is meant to support clinical decision-making, not dictate management.
- Apply these criteria only after a detailed history and physical examination is performed.
- Use only when DVT is being considered; if there is no clinical concern for DVT, risk stratification is unnecessary.
Patients can be categorized as “DVT unlikely” and “DVT likely;” an additional “moderate risk” group can be added depending on the sensitivity of the D-dimer being used.
Score ≤0:
- DVT is unlikely (cited prevalence of 5%).
- Proceed to D-dimer testing.
- A negative moderate- or high-sensitivity D-dimer reduces post-test probability to <1%; no further imaging is required.
- A positive D-dimer should prompt US testing.
- Negative US: Sufficient for DVT rule out.
- Positive US: Consider anticoagulation for DVT.
Score 1–2:
- Moderate risk for DVT (pretest probability 17%).
- Proceed to high-sensitivity D-dimer testing (moderate-sensitivity assays are not sufficient).
- Negative high-sensitivity D-dimer: Sufficiently rules out DVT (post-test probability <1%).
- Positive high sensitivity D-dimer: Proceed to US testing.
- Negative US: Sufficient for ruling out DVT.
- Positive US: Consider anticoagulation for DVT.
Score ≥3:
- DVT is likely (pretest probability 17%–53%).
- Proceed directly to diagnostic US:
- Positive US: Treat DVT.
- Negative US: D-dimer testing can further risk-stratify patients.
- Negative D-dimer:
- DVT is sufficiently ruled out.
- Consider discharge.
- Positive D-dimer:
- Still concerning for DVT.
- Repeat US should be performed within 1 week for re-evaluation.
- Negative D-dimer:
A note on US options:
- A negative whole-leg US (proximal + calf) usually rules out DVT without repeat imaging.
- A negative proximal US may require alternative imaging or repeat US in ~1 week if suspicion remains in moderate- to high-risk patients.
-
Do not rely on the Wells’ Criteria alone to rule out DVT in high-risk patients or when clinical concern remains high.
-
Evaluate for concurrent pulmonary embolism symptoms (e.g., chest pain, dyspnea) that may require urgent escalation in workup and management; decision aids, such as the Wells’ Criteria for PE or PERC Rule, should be considered.
-
Before starting anticoagulation, assess bleeding risk and contraindications; consider applying the RIETE Score.